Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-051998

Director sold 6,750 shares at $56.76 ($383,130)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ajer Jeffrey Robert Director 2018-09-20 Sale −6,750 $56.76 $383,130 15,750 D
Open-market sales · 6,750 sh · avg $56.76 · $383,130
Loading xslF345X03/doc4.xml…